| Tumor stage |
ALNM |
1993 |
p |
1993 |
| |
|
50-59 y |
|
60-69 y |
| Stage Ia-b |
0 |
14 |
n.s. |
19 |
| ≤10 mm |
|
21% |
|
24% |
| Stage Ic |
0 |
25 |
<0.02 |
47 |
| 10–20 mm |
|
38% |
|
59% |
| Stage IIA |
1–3 |
18 |
0.001 |
7 |
| 10–20 mm |
|
27% |
|
9% |
| Stage IIB |
>3 |
8 |
n.s. |
5 |
| 20–50 mm |
|
12% |
|
6% |
| Stage III |
<9 |
1 |
n.s. |
2 |
| >50 mm |
|
2% |
|
2% |
| Σ |
|
66 |
|
80 |
ALNM, axillary lymph node metastasis |
